A GMP Protocol for the Manufacture of Tregs for Clinical Application.
O'Neil A. et al, (2023), 2559, 205 - 227
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.
Cavounidis A. et al, (2022), Mucosal Immunol
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
VanDyke D. et al, (2022), Cell Rep, 41
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.
Lim TY. et al, (2022), J Hepatol
Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.
Shankar S. et al, (2022), Nat Commun, 13
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.
Shankar S. et al, (2022), J Am Soc Nephrol, 33, 883 - 887
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.
Fletcher CE. et al, (2022), Mol Cancer, 21
Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation
Wright S. et al, (2022), ENGINEERING, 10, 30 - 43
Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients.
Bottomley MJ. et al, (2022), Front Immunol, 13
Towards regulatory cellular therapies in solid organ transplantation.
Bottomley MJ. et al, (2022), Trends Immunol, 43, 8 - 21
Chimeric antigen receptors and regulatory T cells: the potential for HLA-directed immunosuppression in transplantation
ISSA F. et al, (2021), Engineering
Biomarkers and Surrogates of Acute Rejection in Vascularized Composite Allograft Transplantation
ISSA F. et al, (2021), Reconstructive Transplantation and Regenerative Medicine The Emerging Interface
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73.
Jarvis LB. et al, (2021), Commun Biol, 4
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
Carr EJ. et al, (2021), Lancet, 398, 1038 - 1041
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury
Cross AR. et al, (2021)
Chimeric antigen receptor-modified human regulatory T cells that constitutively express interleukin-10 maintain their phenotype and are potently suppressive
ISSA F., (2021), European Journal of Immunology